Diabetes patients twice as likely to develop cataract, study finds
Can't see this email? View it online
   
  April 4, 2018  
  Ophthalmology / Optometry  
  The latest ophthalmology / optometry news from News Medical  
 Diabetes patients twice as likely to develop cataract, study findsDiabetes patients twice as likely to develop cataract, study finds
 
People with diabetes are twice as likely to develop cataract as the general population and the relative risk is highest in those aged between 45 and 54, according to a new study published in the journal Eye.
 
 
 Scientists use ‘big-data’ to define burden of sarcoidosisScientists use ‘big-data’ to define burden of sarcoidosis
 
Physician-scientists from the University of Alabama at Birmingham using "big-data" recently summarized in the Journal of the American Heart Association the prevalence of cardiovascular manifestations, rates of defibrillator placement and predictors of in-hospital mortality in sarcoidosis -; a disorder that affects multiple organs.
 
   UNIST researchers introduce new biosensing contact lens for diabeticsUNIST researchers introduce new biosensing contact lens for diabetics
 
A team of researchers, affiliated with UNIST has recently introduced a new biosensing contact lens capable of detecting glucose levels in patients with diabetes.
 
   Research provides new directions in understanding and fighting glaucomaResearch provides new directions in understanding and fighting glaucoma
 
Two distinctive handfuls of short molecules that regulate gene expression have been found in the eye fluid of patients with two distinct types of vision degenerating glaucoma.
 
   Research uses AMSBIO’s 3D organoid technology to develop mouse model of advanced colon cancerResearch uses AMSBIO’s 3D organoid technology to develop mouse model of advanced colon cancer
 
AMSBIO reports on groundbreaking research by the Institute for Research in Biomedicine, Barcelona that cites use of its proprietary 3D organoid technology to develop a mouse model that mimics advanced human colon cancer.
 
   New discovery could help understand and treat glaucomaNew discovery could help understand and treat glaucoma
 
Researchers have discovered two distinct groups of short molecules that regulate gene expression in the eyes of people with two different forms of glaucoma.
 
 Therapeutic target for glaucoma could have treatment ramifications for Alzheimer’s and Parkinson’s
 
Therapeutic target for glaucoma could have treatment ramifications for Alzheimer’s and Parkinson’sA therapeutic target to preserve vision in glaucoma patients could have treatment ramifications for age-related neurodegenerative disorders like Alzheimer's and Parkinson's, according to findings released today in the Proceedings of the National Academy of Sciences.
 
 
 A Look at Hospital Cover in Australia
 
A Look at Hospital Cover in AustraliaAn overview of the hospital cover offered by iSelect.
 
 
 Research findings could help develop new drugs to prevent, treat dry eye disease
 
Research findings could help develop new drugs to prevent, treat dry eye diseaseWith computers, smartphones and contact lenses now essential to modern life, many -- one out of every 10 Japanese people -- suffer dry eye disease.
 
 
 Fraunhofer researchers pursue gentle approach to treat microbial keratitis
 
Fraunhofer researchers pursue gentle approach to treat microbial keratitisMicrobial infections of the cornea can have serious consequences, including blindness in the worst case. The treatment of keratitis, a condition caused by certain pathogens, always presents major challenges to ophthalmologists.
 
 
 Researchers develop gene therapy that treats a form of macular degeneration in canine model
 
Researchers develop gene therapy that treats a form of macular degeneration in canine modelResearchers from the University of Pennsylvania have developed a gene therapy that successfully treats a form of macular degeneration in a canine model.
 
 
 Duke scientists pinpoint new therapeutic target for macular degeneration
 
Duke scientists pinpoint new therapeutic target for macular degenerationDuke Researchers have pinpointed a new therapeutic target for macular degeneration, an eye disease that affects over 10 million Americans and is the leading cause of blindness in adults over 60.
 
 
 Cervical ectropion
 
Cervical ectropionWhen columnar epithelium grows downwards onto this outward-facing portion of the cervix, which is called the ectocervix, it is called Cervical ectropion or erosive cerviciti occurs when columnar epithelium grows downwards onto the ectocervix- the outward-facing portion of the cervix.
 
 
 Researchers find expression of lymphatic markers in proliferative diabetic retinopathy tissues
 
Researchers find expression of lymphatic markers in proliferative diabetic retinopathy tissuesProliferative diabetic retinopathy is a major sight-threatening diabetic complication. Nearly all patients with type I diabetes and over 60% of patients with type II diabetes develop retinopathy after 20 years of diabetes, despite metabolic control.
 
 
 Optogenetics Applications
 
Optogenetics ApplicationsOptogenetics has helped scientists and doctors understand neural circuit behavior and responses in a variety of conditions such as mood disorders, addiction, Parkinson’s disease, obsessive compulsive disorder, social behavior, and reward, to name a few.
 
 
 Robocall increases diabetic retinopathy screening rates among poor minorities
 
Robocall increases diabetic retinopathy screening rates among poor minoritiesAutomated reminder calls may be an effective tool to improve screening for diabetic eye disease among low-income minority patients, especially African Americans, a new study finds. The study results will be presented Monday at ENDO 2018, the Endocrine Society's 100th annual meeting in Chicago, Ill.
 
 
 Researchers link social networks with likelihood of older adults getting cataract surgery
 
Researchers link social networks with likelihood of older adults getting cataract surgeryClose family relationships and a strong social network may help older adults see the world better -- literally.
 
 
 Study highlights potential of ASO therapy to treat Fuchs endothelial corneal dystrophy patients
 
Study highlights potential of ASO therapy to treat Fuchs endothelial corneal dystrophy patientsA proof-of-concept study carried out at UCL Institute of Ophthalmology with funding from Fight for Sight has highlighted the potential of a targeted antisense oligonucleotide therapy to treat Fuchs endothelial corneal dystrophy patients with a mutation in the TCF4 gene.
 
 
 Researchers build better AI algorithms to screen patients for diabetic eye disease
 
Researchers build better AI algorithms to screen patients for diabetic eye diseaseThe ability of artificial intelligence (AI) to help screen patients for a common diabetic eye disease gains momentum with a new study published online today in Ophthalmology, the journal of the American Academy of Ophthalmology.
 
 
 Stem cell-derived ocular cells treat severe AMD
 
Stem cell-derived ocular cells treat severe AMDIn July 2015, 86-year-old Douglas Waters developed severe age-related macular degeneration (AMD). He struggled to see things clearly, even when up close.
 
 
 New NIH study aims to identify biomarkers of AMD progression
 
New NIH study aims to identify biomarkers of AMD progressionA new clinical study led by the National Eye Institute, part of the National Institutes of Health, will follow 500 people over five years to learn more about the natural history of early age-related macular degeneration.
 
 
 Study offers new hope to protect extremely premature babies from impaired vision
 
Study offers new hope to protect extremely premature babies from impaired visionNow there is hope of a new way to protect extremely premature babies from impaired vision or blindness resulting from the eye disease retinopathy of prematurity.
 
 
 Study uncovers new genetic cause of posterior polymorphous corneal dystrophy
 
Study uncovers new genetic cause of posterior polymorphous corneal dystrophyA new genetic cause of corneal dystrophy has been discovered with funding from Fight for Sight by researchers at UCL Institute of Ophthalmology and Moorfields Eye Hospital London, in collaboration with colleagues in the Czech Republic.
 
 
 What is Leber's Hereditary Optic Neuropathy?
 
What is Leber's Hereditary Optic Neuropathy?Leber's Hereditary Optic Neuropathy (LHON) is a subacute form of blindness that develops in early adulthood. Found to occur in males at least 4-5 times more commonly, it is painless and bilateral, with an insidious, but progressive course.
 
 
 Leber Congenital Amaurosis Symptoms
 
Leber Congenital Amaurosis SymptomsLeber congenital amaurosis (LCA) is a congenital cause of severe visual loss. It is an autosomal recessive condition caused by several different mutations in a variety of genes. It is therefore important to identify the cause of the retinopathy using clinical findings and other diagnostic tests to support the diagnosis. Genetic testing has become mandatory to establish the diagnosis.
 
 
 Diabetes and Vision
 
Diabetes and VisionWhen most people think of diabetes, they think of sugar levels and are unaware of the effects it can have on the eyes. Dr. Alan Mendelsohn discusses diabetes associated conditions and how they are managed.
 
 
 Researchers use upconversion nanoparticles to understand brain functions
 
Researchers use upconversion nanoparticles to understand brain functionsScientists from the National University of Singapore have worked with an international research team to jointly develop a novel approach for deep brain stimulation.
 
 
 Children with reading challenges may have lower than expected binocular vision test results
 
Children with reading challenges may have lower than expected binocular vision test resultsElementary school children who read below grade level may have challenges with their eyesight even if standard tests show they see 20/20, according to a new study from the University of Waterloo.
 
 
 UAB scientists explore gene therapy for frontotemporal dementia
 
UAB scientists explore gene therapy for frontotemporal dementiaGene therapy has shown promise for treating a neurodegenerative disease known as frontotemporal dementia and a related condition called neuronal ceroid lipofuscinosis, according to new findings presented in the Journal of Neuroscience by researchers from the University of Alabama at Birmingham.
 
 
 Researchers create minuscule, light-powered wires to modify electrical signaling between neurons
 
Researchers create minuscule, light-powered wires to modify electrical signaling between neuronsThe human brain largely remains a black box: How the network of fast-moving electrical signals turns into thought, movement and disease remains poorly understood. But it is electrical, so it can be hacked--the question is finding a precise, easy way to manipulate electrical signaling between neurons.
 
 
 New report breaks down costs involved in treating complications of type 2 diabetes
 
New report breaks down costs involved in treating complications of type 2 diabetesScientists at the Helmholtz Zentrum München have examined health insurance data of more than 300,000 people with diabetes in Germany.